D-Wave Quantum: Macro Shock, Revenue Collapse and a $100M Government Lifeline Collide at the 200-Day Line

After a stronger-than-expected US jobs report dashed rate cut hopes, D-Wave Quantum shares fell 13% to €20.71, exactly at its 200-day moving average, amid an 81% revenue plunge and new quantum rival Quantinuum's IPO.

Friday’s US jobs report delivered a jolt that rippled straight through the tech sector. With 172,000 new payrolls against a consensus of just 80,000, the data all but erased hopes of near-term Federal Reserve rate cuts. The Nasdaq shed roughly 4% in a single session, wiping out around $2 trillion in market value. For D-Wave Quantum, a stock with a 30-day annualised volatility of nearly 138%, the reaction was brutal: a 13% plunge to €20.71, dragging the weekly loss to almost 20%.

That closing price was not arbitrary. It landed within a cent of D-Wave’s 200-day moving average of €20.70 — a level many institutional investors treat as the dividing line between an intact uptrend and a bear market. The stock now sits 46% below its 52-week high of €38.48, reached last October, and has surrendered roughly 14% since the start of 2026.

A Revenue Wake-Up Call

The macro blow came at a particularly awkward moment for D-Wave’s fundamental narrative. On June 5, Honeywell-backed rival Quantinuum made its Nasdaq debut, pricing at €60 and quickly climbing to €68, raising €1.68 billion. Its CEO positioned the IPO as proof that quantum computing is already generating commercial revenue — a claim that puts D-Wave’s own numbers under an unforgiving spotlight.

D-Wave reported first-quarter revenue of just €2.86 million, an 81% plunge from the same period last year. Against a market capitalisation of roughly €8.77 billion, that leaves a valuation gap that can only be closed by promises of explosive future growth — promises the company has yet to prove it can keep. The 81% drop is not a one-off blip; it raises fundamental questions about the pace of customer adoption and the sustainability of the quantum-as-a-service model.

Technical Crossroads

The 200-day line is now the clearest technical test. The relative strength index stands at 48.5, neutral enough to allow further downside before oversold conditions would typically trigger a bounce. If the moving average breaks, the next major support is the 52-week low of €11.12 from late March 2026 — a potential drop of another 46% from current levels.

Yet the long-term chart tells a different story. Over the past twelve months, D-Wave has still gained 44%. Since that March trough, the advance is 86%. The stock is exactly on its 200-day line, a point that has historically acted as a pivot between trend regimes.

Government Backing and Commercial Milestones

D-Wave is not without ammunition. The US Department of Commerce has earmarked $2 billion for the quantum industry, with $100 million allocated directly to D-Wave. A second funding phase for superconducting qubits with scalable fabrication (SQFab) is also underway. Such state support underscores the strategic value Washington places on domestic quantum capability.

On the commercial front, D-Wave has a two-year QCaaS contract worth $10 million running in production with a Fortune 100 customer. The CFO has pegged the annual revenue capacity of the four operational production systems at $100–$120 million. An additional $20 million system sale to Florida Atlantic University adds to the backlog.

Technologically, D-Wave is pursuing both annealing and gate-model architectures — a dual-track strategy that differentiates it from many peers. In January it announced progress on scalable chip-integrated cryogenic controls, and in June it published a roadmap targeting 100 logical qubits with over one million operations by 2032. The global quantum industry is expected to cross the $1 billion revenue threshold in 2025.

Analysts Still See Upside, but the Clock Is Ticking

The consensus analyst price target stands at €31.62, implying upside of more than 50% from Friday’s close. Yet that optimism looks ambitious given the revenue collapse. Profitability is not expected before 2030, which is standard for emerging tech but leaves the stock dependent on faith rather than fundamentals.

D-Wave is not alone in feeling the squeeze. The entire quantum sector has been repriced as capital flows toward validated winners like Quantinuum. For D-Wave, the burden of proof has shifted squarely onto its next quarterly results. The 200-day line held on Friday. Whether it will survive the next earnings report — and whether the $100 million government grant can outweigh an 81% revenue decline — is the question that will define the stock’s direction for the rest of 2026.